Streubel A, Siepmann J, Dashevsky A, Bodmeier R
College of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169, Berlin, Germany.
J Control Release. 2000 Jun 15;67(1):101-10. doi: 10.1016/s0168-3659(00)00200-5.
Weakly basic drugs or salts thereof demonstrate pH-dependent solubility. The resulting release from conventional matrix tablets decreases with increasing pH-milieu of the gastrointestinal tract. The aim of this study was to overcome this problem and to achieve pH-independent drug release. Two different polymers were used as matrix formers, the water-insoluble and almost unswellable ethylcellulose (EC), and the water-soluble and highly swellable hydroxypropyl methylcellulose (HPMC). Two different approaches to solve the problem of pH-dependent release of weakly basic drugs are demonstrated in this paper. The first one is based on the addition of hydroxypropyl methylcellulose acetate succinate (HPMCAS, an enteric polymer), the second one on the addition of organic acids such as fumaric, succinic or adipic acid to the drug-polymer system. The first approach failed to achieve pH-independent drug release, whereas the addition of organic acids to both matrix formers was found to maintain low pH values within the tablets during drug release in phosphate buffer (pH 6.8 or 7.4). Thus, the micro-environmental conditions for the dissolution and diffusion of the weakly basic drug were almost kept constant. The release of verapamil hydrochloride from tablets composed of ethylcellulose or HPMC and organic acids was found to be pH-independent.
弱碱性药物或其盐类表现出pH依赖性溶解度。传统基质片剂的药物释放量会随着胃肠道pH值环境的升高而降低。本研究的目的是克服这一问题并实现pH无关型药物释放。使用了两种不同的聚合物作为基质形成剂,即水不溶性且几乎不溶胀的乙基纤维素(EC),以及水溶性且高度溶胀的羟丙基甲基纤维素(HPMC)。本文展示了两种解决弱碱性药物pH依赖性释放问题的不同方法。第一种方法是基于添加醋酸羟丙基甲基纤维素琥珀酸酯(HPMCAS,一种肠溶聚合物),第二种方法是在药物 - 聚合物体系中添加富马酸、琥珀酸或己二酸等有机酸。第一种方法未能实现pH无关型药物释放,而在向两种基质形成剂中添加有机酸后发现,在磷酸盐缓冲液(pH 6.8或7.4)中药物释放期间片剂内部能保持低pH值。因此,弱碱性药物溶解和扩散的微环境条件几乎保持恒定。由乙基纤维素或HPMC与有机酸组成的片剂中盐酸维拉帕米的释放被发现是pH无关型的。